South Korean medical AI company Vuno has recently secured 10 billion won ($6.9 million) in strategic investment for its ...
Tarsus Pharmaceuticals remains a Strong Buy, driven by Xdemvy's robust growth and management's $2B+ peak sales target. Click ...
Implantables net sales were $474 million, an increase of 4%. Excluding favorable currency impacts of 2%, Implantables net sales increased 2% constant currency. This growth reflects strong performance ...
Fellow shareholders, Axon completed another record year in pursuit of our mission to protect life. Revenue grew 33% year over year, marking our fourth consecutive year of annual g ...
A misinterpreted requirement or a missed edge case could take months to unwind. That reality shaped behavior. Teams debated longer. Documents grew heavier. Product requirements documents (PRDs), in ...
The world's most critical challenges are accelerating at a rapid pace. The R&D methods tasked with solving them are not—until ...
The study, named IDEAL ( IaDademstat treatment for EssentiAL thrombocythemia ), is a multicenter, single-arm Phase II study to be conducted in Spain in adult patients with ET who are ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® ...
Design engineers can use AI-driven simulation to overcome bottlenecks and accelerate materials discovery with hybrid workflow ...
Sunny Agarwal of SBI Securities sees markets at fair valuations, bullish on banks and select midcaps; shares top stock picks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results